Anticoagulant drugs in noncompaction: A mandatory therapy?

Journal of Cardiovascular Medicine

Volumn 9, Issue 11, 2008, Pages 1095-1097

  Fazio, Giovanni ^a,n   Corrado, Giovanni ^b   Zachara, Elisabetta ^d   Rapezzi, Claudio ^c   Sulafa, Ali K ^e   Sutera, Loredana ^a   Stollberger, Claudia ^f   Sormani, Luca ^b   Finsterer, Joseph ^g   Benatar, Abraham ^h   Di Gesaro, Gabriele ^a   Visconti, Claudia ^a   Dangelo, Luciana ^a   Novo, Giuseppina ^a   Mongiovi, Maurizio ^m   Cavusoglu, Yuksel ⁱ   Baumhakel, Magnus ^j   Drago, Fabrizio ^k   Indovina, Giuseppe ^a   Ferrara, Filippo ^a   Carerj, Scipione ^l   Pipitone, Salvatore ^m   Novo, Salvatore ^a   more..

^a UNIVERSITY OF PALERMO   (Italy)

^b VALDUCE HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e Divisions of Pediatric Cardiology and Cardiac Surgery   (Saudi Arabia)

^f 2nd Medical Department

^g KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^h FREE UNIVERSITY OF BRUSSELS   (Belgium)

ⁱ ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^j SAARLAND UNIVERSITY   (Germany)

^k BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^l UNIVERSITY OF MESSINA   (Italy)

^m Casa del Sole Hospital   (Italy)

ⁿ NONE   (Italy)

more..

Author keywords

Anticoagulant; Embolism; Ischemic stroke; Isolated left ventricular noncompaction; Thrombus

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; BEHCET DISEASE; CARDIAC PATIENT; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CHILD; ELECTROCARDIOGRAM; EVALUATION; FEMALE; FOLLOW UP; HEART MUSCLE; HEART VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REGISTER; RISK FACTOR; STROKE; SYSTOLIC DYSFUNCTION; THROMBOEMBOLISM; THROMBOGENESIS; THROMBUS; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DRUG EFFECT; HEART VENTRICLE; INFANT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TIME;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; CARDIOMYOPATHIES; FEMALE; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; STROKE; THROMBOEMBOLISM; TIME FACTORS;

EID: 58149396788     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328308da04     Document Type: Article

References (10)

1. Ker J, Van Der Merwe C. Isolated left ventricular noncompaction as a cause of thrombo-embolic stroke: a case report and review. Cardiovasc J S Afr 2006; 17:146-147.
2. Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc 1997; 72:26-31.
3. Hascelik S, Yalnizoglu D, Kafali G, Celiker A, Cila A, Topcu M, Gurgey A. Stroke owing to noncompaction of myocardium. J Child Neurol 2003; 18:437-439.
4. Stollberger C, Finsterer J. Thrombi in left ventricular hypertrabeculation/ noncompaction: review of the literature. Acta Cardiol 2004; 59:341-344.
5. Stollberger C, Finsterer J. Left ventricular hypertrabeculation/ noncompaction and stroke or embolism. Cardiology 2005; 103:68-72.
6. Toyono M, Kondo C, Nakajima Y, Nakazawa M, Momma K, Kusakabe K. Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular noncompaction. Heart 2001; 86:4-6.
7. Hruda J, Sobotka-Plojhar MA, Fetter WP. Transient postnatal heart failure caused by noncompaction of the right ventricular myocardium. Pediatr Cardiol 2005; 26:452-454.
8. Murphy RT, Thaman R, Blanes JG, Ward D, Sevdalis E, Papra E, et al. Natural history and familial characteristics of isolated left ventricular noncompaction. Eur Heart J 2005; 26:187-192.
9. Belgnaoui F, Raki S, Douira L, Benabdellah L, Rimani M, Labraimi A, et al. Highly thrombogenic forms of Behcet's disease associated with Castleman's disease and renal amyloidosis. Ann Dermatol Venereol 2006; 133:278-280.
10. Fuster V,Ryden LE, Cannom DS, Crijns HJ, Curtis AB, EllenbogenKA,et al. 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8:651-745.